1-cyclohexyl-3-(2-(4-morpholinyl)ethyl)carbodiimide has been researched along with Autosomal Dominant Striatonigral Degeneration in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Hou, X; Jiang, H; Peng, H; Peng, L; Qiu, R; Shen, L; Shi, Y; Tang, B; Tang, Z; Wan, L; Wang, C; Xia, K; Zou, G | 1 |
1 other study(ies) available for 1-cyclohexyl-3-(2-(4-morpholinyl)ethyl)carbodiimide and Autosomal Dominant Striatonigral Degeneration
| Article | Year |
|---|---|
Characterization of the central motor conduction time in a large cohort of spinocerebellar ataxia type 3 patients.
Topics: Evoked Potentials, Motor; Humans; Machado-Joseph Disease; Neural Conduction; Transcranial Magnetic Stimulation | 2022 |